Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative drugs to improve the lives of cancer patients. With a keen eye on overcoming drug resistance, its flagship ...
Japan’s Ono Pharma has bolstered its cancer pipeline with a $2.4 billion agreement to buy Deciphera Pharma of the US and its fast-growing gastrointestinal stromal tumour (GIST) therapy Qinlock. Ono is ...
Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback